Astrana Health, Inc.
ASTH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,035 | $1,387 | $1,144 | $774 |
| % Growth | 46.7% | 21.2% | 47.8% | – |
| Cost of Goods Sold | $1,763 | $1,172 | $945 | $596 |
| Gross Profit | $271 | $215 | $199 | $178 |
| % Margin | 13.3% | 15.5% | 17.4% | 23% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $154 | $113 | $78 | $62 |
| SG&A Expenses | $154 | $113 | $78 | $62 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $28 | $18 | $18 | $18 |
| Operating Expenses | $182 | $130 | $95 | $80 |
| Operating Income | $89 | $85 | $104 | $98 |
| % Margin | 4.4% | 6.1% | 9.1% | 12.7% |
| Other Income/Exp. Net | -$9 | $5 | -$18 | -$20 |
| Pre-Tax Income | $81 | $90 | $87 | $78 |
| Tax Expense | $31 | $32 | $41 | $32 |
| Net Income | $43 | $61 | $45 | $69 |
| % Margin | 2.1% | 4.4% | 3.9% | 8.9% |
| EPS | 0.91 | 1.3 | 1 | 1.57 |
| % Growth | -30% | 30% | -36.3% | – |
| EPS Diluted | 0.9 | 1.29 | 0.99 | 1.52 |
| Weighted Avg Shares Out | 48 | 47 | 45 | 44 |
| Weighted Avg Shares Out Dil | 48 | 47 | 46 | 45 |
| Supplemental Information | – | – | – | – |
| Interest Income | $15 | $14 | $2 | $2 |
| Interest Expense | $33 | $16 | $8 | $5 |
| Depreciation & Amortization | $28 | $18 | $18 | $18 |
| EBITDA | $142 | $124 | $112 | $101 |
| % Margin | 7% | 8.9% | 9.8% | 13% |